Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Wilshire Pharmaceuticals, Inc., updating the existing NDA.
-
FDA label_change · 2016-11-18FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride from Teva Pharmaceuticals Inc.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
The FDA approved a supplemental application for verapamil hydrochloride from Exela Pharma Sciences, LLC.
-
FDA approval · 2016-11-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride. The approval confirms a modification to the pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-18FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of aspirin plus clopidogrel in atrial fibrillation patients at low to moderate strok…
-
FDA approval · 2016-11-08FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for MATZIM LA, a diltiazem hydrochloride product from Actavis Pharma, Inc.
-
CLINICAL_TRIALS research · 2016-11-08Clinical Trial Update: Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation
An ongoing clinical trial update from Peking University Third Hospital examining whether fibroblast growth factor 23 levels are associated w…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Management of New-Onset Postoperative Atrial Fibrillation
A completed clinical trial from Emory University examines management strategies for new-onset postoperative atrial fibrillation.
-
CLINICAL_TRIALS research · 2016-11-03Clinical Trial Update: Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study)
An update on a clinical trial evaluating screening for silent atrial fibrillation in high-risk individuals (The Silence Study).
-
FDA label_change · 2016-11-02FDA Approved: DIGOXIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for digoxin from Sandoz Inc, resulting in a label change for the generic heart medication.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk. [NA]
This completed study evaluated whether the number of risk diagrams and the period used to estimate risk influence decisions to prescribe or …
-
FDA label_change · 2016-10-31FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) to update the product labeling, as filed by Baxter Healthca…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: A Pilot Study of a Contact Force Catheter for Pulmonary Vein Antrum Isolation [Phase 2]
This Phase 2 pilot trial update reports completion of a study evaluating a contact force catheter for pulmonary vein isolation in atrial fib…
-
CLINICAL_TRIALS withdrawal · 2016-10-26Clinical Trial Update: Omega 3 Fatty Acids and Atrial Fibrillation [NA]
A clinical trial evaluating omega-3 fatty acids for atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea [NA]
A terminated clinical trial from the University of Zurich examined whether premature atrial beats originate from simulated obstructive sleep…
-
CLINICAL_TRIALS withdrawal · 2016-10-25Clinical Trial Update: Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial comparing warfarin versus aspirin in patients with atrial fibrillation and chronic kidney disease has been withdraw…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Stroke Feasibility Study [Phase 1, Phase 2]
AtriCure reported results from a Phase 1/2 stroke feasibility study in patients with atrial fibrillation; the study has completed and result…
-
FDA approval · 2016-10-21FDA Approved: SOTALOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved an original ANDA for sotalol hydrochloride (Sotalol) from Unichem Pharmaceuticals (USA), Inc., enabling generic access to this …
-
CLINICAL_TRIALS research · 2016-10-20Clinical Trial Update: Catheter Ablation of Longstanding Persistent Atrial Fibrillation [NA]
This entry provides a clinical trial update on catheter ablation for longstanding persistent atrial fibrillation. The current status of the …
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine [Phase 3]
Phase 3 trial completed evaluating whether catheter ablation alters the clinical course of migraine in patients with atrial fibrillation, wi…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm [Phase 3]
A Phase 3 study evaluating vanoxerine for converting recent-onset atrial fibrillation or flutter to normal sinus rhythm; the trial was termi…
-
CLINICAL_TRIALS research · 2016-10-10Clinical Trial Update: NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease
An update on a trial evaluating novel oral anticoagulants for atrial tachyarrhythmias in congenital heart disease. The sponsor is AMC-UvA, a…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults [NA]
A completed clinical trial evaluating magnesium therapy to prevent postoperative atrial fibrillation after cardiac surgery in adults.